Metraipolis › archive › dc_c2125c8fe65a

OPTIMISE-ing consent in clinical trials: recommendations for designing accessible consent processes to address communication and decision-making needs as a… — Europe PMC PPR:PPR1278084

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR1278084
DOI
10.21203/rs.3.rs-9990455/v1
License (as archived)
solo-consultazione
Archived
2026-10-18T07:50:42.490Z
SHA-256 of the archived text
12e479619e60f637271982b7cdee1fb37f135fc836161ddcde2a024a2d36a483
Stable URL of this page
https://metraipolis.com/documento/dc_c2125c8fe65a

How to cite

OPTIMISE-ing consent in clinical trials: recommendations for designing accessible consent processes to address communication and decision-making needs as a… — Europe PMC PPR:PPR1278084 — Europe PMC, https://europepmc.org/article/PPR/PPR1278084 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c2125c8fe65a (Metraipolis archive dc_c2125c8fe65a, sha256 12e479619e60f637271982b7cdee1fb37f135fc836161ddcde2a024a2d36a483)
BibTeX
@misc{dcc2125c8fe65a,
  title = {OPTIMISE-ing consent in clinical trials: recommendations for designing accessible consent processes to address communication and decision-making needs as a… — Europe PMC PPR:PPR1278084},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR1278084},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c2125c8fe65a; sha256 12e479619e60f637271982b7cdee1fb37f135fc836161ddcde2a024a2d36a483},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1278084. Agents can read the archived copy with the MCP tool read_document.